Cartesian Therapeutics (RNAC) EBITDA Margin (2015 - 2026)
Cartesian Therapeutics (RNAC) recorded EBITDA Margin of -33184.62% in Q1 2026, down 31299.80 percentage points from -1884.82% a year earlier and down 24944.81 percentage points from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) EBITDA Margin (2015 - 2026) Analysis & Trends
For FY2025, Cartesian Therapeutics reported EBITDA Margin of -5021.31%, down 4911.46 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -4683.37 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -109.85% in FY2024 (+219.23 pp), -329.08% in FY2023 (-343.36 pp), 14.29% in FY2022 (+18.22 pp) and -3.93% in FY2021 (+334.00 pp).
- The Q1 2026 figure is the lowest quarterly EBITDA Margin since Q2 2019.
- On a year-over-year basis, EBITDA Margin rose in 1 of the last six quarters, with an average year-over-year change of -7343.16 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 393.44 percentage points in Q2 2024, against a drop of 31299.80 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -8239.81% (Q4 2025), -4526.55% (Q3 2025) and -7121.48% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 39.16% |
| 10 | Cartesian Therapeutics | 192.72 Mn | -342.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -32,883.33% |
| Dec 31, 2025 | -8,217.11% |
| Sep 30, 2025 | -4,484.07% |
| Jun 30, 2025 | -7,058.72% |
| Mar 31, 2025 | -1,868.09% |
| Sep 30, 2024 | -4,298.71% |
| Jun 30, 2024 | 43.52% |
| Mar 31, 2024 | -216.66% |
| Dec 31, 2023 | -430.49% |
| Sep 30, 2023 | -189.89% |
| Jun 30, 2023 | -343.61% |
| Mar 31, 2023 | -299.07% |
| Dec 31, 2022 | -46.73% |
| Sep 30, 2022 | -4.39% |
| Jun 30, 2022 | 36.93% |
| Mar 31, 2022 | 33.58% |
| Dec 31, 2021 | 15.92% |
| Sep 30, 2021 | -5.51% |
| Jun 30, 2021 | 5.26% |
| Mar 31, 2021 | -60.44% |
API Access
Cartesian Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();